Angel Invest Boston

Sponsors: Purdue University entrepreneurship Peter Fasse, patent attorney at Fish & Richardson Mostly diagnosed in late stages, ovarian cancer is a silent killer of women. Oriana Papin-Zoghbi of AOA Dx aims to defeat this threat. Fresh out of Y Combinator, the team is making impressive headway in commercializing a promising technology from McGill University. Highlights: Sal Introduces Sponsors, Purdue University Entrepreneurship & Peter Fasse, Patent Attorney Sal Daher, CFA Welcomes Oriana Papin-Zoghbi of AOA Dx to the Podcast Ovarian Cancer Is a Silent Killer of Women “None of us on the founding team were originally scientists... We needed to really create a partnership.” Partnered with Professor Uri Saragovi of McGill University “...80% of cases being diagnosed when they're already Stage III and IV.” Professor Saragovi’s Approach Is Using Certain Glycolipids in the Patient’s Blood as a Marker of the Presence of Ovarian Cancer AOA Dx Supported by a Retrospective Study – Reached 95% Accuracy Sal Da